I'd like to engineer an existing mouse model which normally develops relatively few spontaneous mutations. By delivering an shRNA or a dominant negative enzyme, I'd like to make this model more prone to the development of point mutations. Ideally, like tobacco carcinogens do. What should I target? NER components? ATM/ATR? Could you point me to some references? Thanks.

Similar questions and discussions